The Journal of Experimental Medicine · 1997 · 509 citations · 29 references
Life SciencesCell BiologyImmunologyApoptosisCell SignalingSignal TransductionApoptotic SignalingCell DeathDeath ReceptorsCell Surface Death ReceptorsDeath Ligand SignalingFas LigandFas Ligand-mediated ApoptosisFas-associated Death Domain ProteinFas-fas Ligand Mediated KillingImmune Cell CytotoxicityNaive T Cells
It has been believed that the Fas expressed on human peripheral blood T cells (PBT) is nonfunctional, because these cells are insensitive to agonistic anti-Fas/Apo-1 mAbs that efficiently kill in vitro-activated T cells and many Fas-expressing cell lines. Here, we demonstrate that membrane-bound Fas ligand (FasL) kills both fresh and in vitro-activated PBT, indicating that the Fas expressed on fresh PBT is functional. In contrast, soluble FasL kills only the latter. Naive T cells in umbilical cord blood do not express Fas, but can be induced to express Fas by IFN-gamma or by a combination of IL-2 and anti-CD28 mAb, after which they acquire sensitivity to membrane but not to soluble FasL. Soluble FasL inhibited the killing of fresh PBT by membrane FasL. These results indicate that the shedding of FasL from the membrane is a mechanism for downregulating at least part of its killing activity.
29
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Roy A. Black, Charles T. Rauch, Carl J. Kozlosky et al. · Nature · 1997 · 3.1K citations
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Thomas S. Griffith, Thomas Brunner, Sharon M. Fletcher et al. · Science · 1995 · 2K citations
Medicine, Immunology, Ophthalmology +17
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
B. C. Trauth, C Klas, Anke Peters et al. · Science · 1989 · 1.7K citations · Full text